Fake medicines kill half a million yearly—why traffickers still evade justice

Fake and substandard medicines are killing hundreds of thousands of people every year, yet those responsible often escape justice. In regions like the Sahel, one in ten medical products fails quality checks, contributing to around 500,000 preventable deaths annually. Now, legal experts are pushing for systematic pharmaceutical counterfeiting to be treated as an international crime rather than a minor regulatory offence. The scale of the problem is vast. In 2025 alone, INTERPOL’s Operation Pangea XVII seized over 50 million doses of illicit drugs across 90 countries. Yet bringing traffickers to account remains difficult. Many developing nations lack the forensic capacity to prove that a death resulted from a fake pill rather than an existing illness. Even when evidence exists, national courts often treat intellectual property crimes as low-priority civil matters, leaving a legal void.

The International Criminal Court (ICC) could step in, but its principle of *complementarity* means it only acts when states fail to prosecute. South Africa and other countries frequently overlook IP offences, creating safe havens for traffickers. A further hurdle lies in bridging the gap between enforcement data—collected by bodies like WIPO and INTERPOL—and the ICC’s strict evidentiary standards. Legal shifts may now change this. The ICC’s 2025 Policy on Cyber-Enabled Crimes clarifies that digital theft of intellectual property, when linked to mass harm, can fall under the Court’s jurisdiction. This connects the online trade of fake drugs to the physical devastation they cause. Article 7(1)(k) of the Rome Statute also offers a pathway: it covers acts causing ‘great suffering’ or ‘serious injury’, including cases like distributing chalk-based ‘antibiotics’ in war zones. Reclassifying systematic medical falsification as an ‘inhumane act’ would reframe the issue. Instead of treating it as a consumer protection matter, it would centre on victims’ rights. This could hold traffickers accountable even if profit, not murder, was their primary motive.

The push to recognise pharmaceutical counterfeiting as an international crime marks a turning point. If successful, it would close legal loopholes that allow traffickers to operate with impunity. For the half-million people who die each year from fake medicines, this shift could finally bring justice within reach.